| Drug Name: | Lenalidomide (191732-72-6) |
|---|---|
| PubChem ID: | 216326 |
| SMILES: | C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N |
| InchiKey: | GOTYRUGSSMKFNF-UHFFFAOYSA-N |
| Therapeutic Category: | Angiogenesis Inhibitors, Angiogenesis Modulating Agents, Antineoplastic Agents, Growth Inhibitors, Growth Substances, Immunologic Factors |
| Molecular Weight (dalton) | : | 259.265 |
| LogP | : | 0.0298 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 4 |
| Hydrogen Bond Donor Count | : | 2 |
| Total Polar Surface Area | : | 92.5 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category